The biopsy devices market in China is expected to reach a projected revenue of US$ 220.1 million by 2030. A compound annual growth rate of 10.9% is expected of China biopsy devices market from 2024 to 2030.
Cardinal Health Inc, Hologic Inc, Danaher Corp, Conmed Corp, Cook Medical, Inrad Optics Inc, TransMedics Group Inc, DTR Medical, Gallia County Health Department
Other key industry trends
In terms of revenue, China accounted for 4.7% of the global biopsy devices market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, Japan biopsy devices market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 163.5 million by 2030.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biopsy Devices Market will help companies and investors design strategic landscapes.
Needle-Based Biopsy Guns was the largest segment with a revenue share of 43.96% in 2023.
Horizon Databook has segmented the China biopsy devices market based on needle-based biopsy guns, biopsy guidance systems, biopsy needles, biopsy forceps covering the revenue growth of each sub-segment from 2018 to 2030.
China Biopsy Devices Market Product Outlook (Revenue, USD Million , 2018-2030)
Needle-based Biopsy Guns
Biopsy Guidance Systems
Biopsy Needles
Biopsy Forceps
Others
Reasons to subscribe to biopsy devices industry databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of biopsy devices industry databook
Our clientele includes a mix of biopsy devices industry companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China biopsy devices industry, including forecasts for subscribers. This country databook contains high-level insights into China biopsy devices industry from 2018 to 2030, including revenue numbers, major trends, and company profiles.